mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |